Atara Biotherapeutics' Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases [Yahoo! Finance]
Atara Biotherapeutics, Inc. (ATRA)
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.atarabio.com/investor-relations
Company Research
Source: Yahoo! Finance
THOUSAND OAKS, Calif., June 21, 2024 BUSINESS WIRE Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Ebvallo TM (tabelecleucel or tab-cel ® ) has been awarded the prestigious 2024 Prix Galien International Award for "Best Product for Orphan/Rare Diseases." The award was presented to Pierre Fabre Laboratories, Atara's global development and commercialization partner for Ebvallo. The Prix Galien International Awards for Life Science Research is organized every two years and is judged by a committee of distinguished independent experts and specialists. They select the most innovative therapy from the winners of the 15 National Prix Galien awards in each category over the previous two years. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceu
Show less
Read more
Impact Snapshot
Event Time:
ATRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRA alerts
High impacting Atara Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ATRA
News
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceBusiness Wire
- Atara Biotherapeutics Announces $36 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Atara Biotherapeutics Announces $36 Million Registered Direct OfferingBusiness Wire
- Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London [Yahoo! Finance]Yahoo! Finance
ATRA
Earnings
- 8/12/24 - Miss
ATRA
Sec Filings
- 9/13/24 - Form SC
- 9/11/24 - Form 4
- 9/5/24 - Form 3
- ATRA's page on the SEC website